Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Haem oxygenase‐1 expression is diminished in alveolar macrophages of patients with COPD

D‐J. Slebos, H.A.M. Kerstjens, S.R. Rutgers, H.F. Kauffman, A.M.K. Choi, D.S. Postma
European Respiratory Journal 2004 23: 652-653; DOI: 10.1183/09031936.04.00127904
D‐J. Slebos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.A.M. Kerstjens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.R. Rutgers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.F. Kauffman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.M.K. Choi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.S. Postma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editor:

We read with great interest the paper by Maestrelli et al. 1 recently published in the European Respiratory Journal (ERJ). They showed a lower expression of haem oxygenase‐1 (HO‐1) in alveolar macrophages in lung tissue samples of patients with chronic obstructive pulmonary disease (COPD) than of controls. Unfortunately, the authors included a mixed group of smokers and nonsmokers. This makes their results more difficult to interpret since cigarette smoke is known to influence HO‐1 expression as shown in an earlier paper by the same authors 2. Furthermore, the lung tissue samples in their COPD patient group were mainly derived by lung volume resection surgery and in the control group from resection because of lung cancer 1. We have recently analysed bronchoalveolar lavage (BAL) fluid of exsmokers with COPD and compared these to healthy exsmokers thereby ruling out the effects of current smoking history.

Thirteen patients with COPD, according to American Thoracic Society (ATS) criteria, were included with a mean age of 64 yrs, forced expiratory volume in one second (FEV1) 59% predicted, reversibility 6.0% of pred FEV1, and 26 pack-yrs of smoking. Eleven age matched control subjects were recruited, with a mean age of 58 yrs, FEV1 103% pred, reversibility 3.4% of pred FEV1, and 25 pack-yrs 3. All subjects had no history of asthma or atopy and had a negative skin test for 18 common aeroallergens. Treatment with inhaled corticosteroids was discontinued at least 1 month prior to the study and no treatment with oral corticosteroids and antibiotics was allowed in the same period. The airways were lavaged, using the first 50 mL for bronchial wash and the subsequent 150 mL for bronchoalveolar lavage as described previously 3. The lavage alveolar macrophage count was comparable in both groups. Immunostaining of cytospins was performed with a monoclonal antibody against HO‐1 (Beckton Dickinson, Franklin Lakes, NJ, USA). Total HO‐1 expression on macrophages was scored semi-quantitatively in a blinded panel by two independent observers; scores ranged from 0 (negative), 1, 2, to 3 (maximal) according to increasing intensity. Four hundred alveolar macrophages were counted on two slides and the HO‐1 scores were added up. The overall HO‐1 expression of BAL alveolar macrophages was significantly lower in the exsmoking COPD patients when compared to the healthy exsmoking controls (fig. 1⇓).

Fig. 1.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.—

Total haem oxygenase‐1 (HO‐1) expression. Semi-quantitative total score of HO-1 expression on alveolar macrophages in bronchoalveolar lavage fluid for exsmoking chronic obstructive pulmonary disease patients (○) and age-matched healthy exsmoking controls (□). The horizontal line represents the median. #: p=0.018.

The lower expression of haem oxygenase‐1 in lavage macrophages observed in our patients with moderate-to-severe chronic obstructive pulmonary disease (Global initiative for Chronic Obstructive Lung Disease stage 2–3, 4) corroborates the findings of Maestrelli et al. 1 on surgical specimens. It extends their findings in that this decreased expression is also present in patients and controls without current smoking, i.e. smoking does not directly influence the haem oxygenase‐1 expression. Haem oxygenase‐1 has very potent anti-oxidative and anti-inflammatory capacities, for instance protection against allograft rejection and hyperbaric oxygen injury in animal models 5. The results of Maestrelli et al. 1 and our own results are compatible with the hypothesis that haem oxygenase‐1 is insufficiently upregulated in chronic obstructive pulmonary disease. This might be due to genetic polymorphisms: Yamada et al. 6 for instance have shown a larger number of (GT)n repeats in the haem oxygenase‐1 gene promoter to decrease inducibility of haem oxygenase‐1 by reactive oxygen species. We believe that further research to elucidate the exact role of haem oxygenase‐1, its genetic variability and its downstream products in chronic obstructive pulmonary disease is warranted.

    • © ERS Journals Ltd

    References

    1. ↵
      Maestrelli P, Paska C, Saetta M, et al. Decreased haem oxygenase‐1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. Eur Respir J 2003;21:971–976.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Maestrelli P, El Messlemani AH, De Fina O, et al. Increased Expression of Heme Oxygenase (HO)‐1 in Alveolar Spaces and HO‐2 in Alveolar Walls of Smokers. Am J Respir Crit Care Med 2001;164:1508–1513.
      OpenUrlCrossRefPubMedWeb of Science
    3. ↵
      Rutgers SR, Timens W, Kaufmann HF, van der Mark TW, Koeter GH, Postma DS. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000;15:109–115.
      OpenUrlAbstract/FREE Full Text
    4. ↵
      Fabbri LM, Hurd SS, GOLD Scientific Committee. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J 2003;22:1–2.
      OpenUrlFREE Full Text
    5. ↵
      Slebos DJ, Ryter SW, Choi AM. Heme oxygenase‐1 and carbon monoxide in pulmonary medicine. Respir Res 2003;4:7.
      OpenUrlCrossRefPubMed
    6. ↵
      Yamada N, Yamaya M, Okinaga S, et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000;66:187–195.
      OpenUrlCrossRefPubMedWeb of Science
    View Abstract
    PreviousNext
    Back to top
    View this article with LENS
    Vol 23 Issue 4 Table of Contents
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Haem oxygenase‐1 expression is diminished in alveolar macrophages of patients with COPD
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Haem oxygenase‐1 expression is diminished in alveolar macrophages of patients with COPD
    D‐J. Slebos, H.A.M. Kerstjens, S.R. Rutgers, H.F. Kauffman, A.M.K. Choi, D.S. Postma
    European Respiratory Journal Apr 2004, 23 (4) 652-653; DOI: 10.1183/09031936.04.00127904

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Haem oxygenase‐1 expression is diminished in alveolar macrophages of patients with COPD
    D‐J. Slebos, H.A.M. Kerstjens, S.R. Rutgers, H.F. Kauffman, A.M.K. Choi, D.S. Postma
    European Respiratory Journal Apr 2004, 23 (4) 652-653; DOI: 10.1183/09031936.04.00127904
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Treatable traits in ILD: why not consider acute exacerbations?
    • Inclusion of lung health outcomes in TB treatment trials
    • Confounding is a risk for all observational designs
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2023 by the European Respiratory Society